1 | L S R, D M K, AHMEDIN J. Cancer statistics[J]. CA Cancer J Clin, 2019,69(1):7-34. |
2 | KUJAN O, HUANG G, RAVINDRAN A, et al. CDK4, CDK6, cyclin D1 and Notch1 immunocytochemical expression of oral brush liquid-based cytology for the diagnosis of oral leukoplakia and oral cancer[J].J Oral Pathol Med,2019,48(7): 566-573. |
3 | CHATTERJEE R, CHATTERJEE J. ROS and oncogenesis with special reference to EMT and stemness[J]. Eur J Cell Biol, 2020, 99(2/3): 151073. |
4 | RHEE S G, WOO H A, KIL I S, et al. Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides[J]. J Biol Chem, 2012, 287(7):4403-4410. |
5 | 吕丽娜, 黄赞松, 王小超. PRDX家族蛋白与肿瘤的发生发展[J]. 右江民族医学院学报,2018,40(2):188-190. |
6 | QIAO B B, WANG J J, XIE J F, et al. Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach[J]. Int J Mol Med, 2012, 29(5): 832-840. |
7 | ZHAI L L,YANG J, JU T F.Diagnostic and prognostic values of peroxiredoxin-1 expression in human pancreatic carcinoma[J]. Pancreatology, 2017,17(4):556. |
8 | LU Y, LIU J, LIN C, et al. Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasma[J]. BMC Gastroenterol, 2010, 10: 115. |
9 | FENG Y, TIAN Z M, WAN M X, et al. Protein profile of human hepatocarcinoma cell line SMMC-7721: identification and functional analysis[J]. World J Gastroenterol, 2007, 13(18): 2608-2614. |
10 | CHOWDHURY I, MO Y Q, GAO L, et al. Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element[J]. Free Radic Biol Med, 2009, 46(2): 146-153. |
11 | HU X L, LU E M, PAN C Y, et al. Overexpression and biological function of PRDX6 in human cervical cancer[J]. J Cancer, 2020, 11(9): 2390-2400. |
12 | HUANG W S, HUANG C Y, HSIEH M C, et al. Expression of PRDX6 correlates with migration and invasiveness of colorectal cancer cells[J]. Cell Physiol Biochem, 2018, 51(6): 2616-2630. |
13 | JO M, YUN H M, PARK K R, et al. Lung tumor growth-promoting function of peroxiredoxin 6[J]. Free Radic Biol Med, 2013, 61: 453-463. |
14 | 杨海玉, 柯 波, 文丽丹, 等. 急性髓系白血病患者Peroxiredoxin-6基因表达及其临床意义[J]. 中国实验血液学杂志, 2020, 28(4): 1157-1161. |
15 | 杨海玉. 过氧化物酶与急性髓系白血病的研究进展[J]. 临床与病理杂志, 2020, 40(1): 136-139. |
16 | MUHLBAUER J,PHELAN S A.PRDX overexpression in tumor tissue of brease cancer patients[J].Int J Cancer Res, 2016, 3(2):53. |
17 | 何 燕. 抗氧化蛋白Prdx6在食管癌中的表达及生物学功能研究[D]. 苏州: 苏州大学, 2016. |
18 | SCHMITT A, SCHMITZ W, HUFNAGEL A, et al. Peroxiredoxin 6 triggers melanoma cell growth by increasing arachidonic acid-dependent lipid signalling[J]. Biochem J, 2015, 471(2): 267-279. |
19 | YUN H M, PARK K R, PARK M H, et al. PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model[J]. Free Radic Biol Med, 2015, 80:136-144. |
20 | CHOWDHURY I, FISHER A B, CHRISTOFIDOU-SOLOMIDOU M, et al. Keratinocyte growth factor and glucocorticoid induction of human peroxiredoxin 6 gene expression occur by independent mechanisms that are synergistic[J]. Antioxid Redox Signal, 2014, 20(3): 391-402. |
21 | YUN H M, PARK K R, LEE H P, et al. PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities[J]. Free Radic Biol Med, 2014, 69: 367-376. |
22 | 陈建安,陈思玉,刘丽文,等.高迁移率族蛋白2在肝癌组织中的表达及对肝癌细胞生物学活性的影响[J].郑州大学学报(医学版),2019,54(1):9-15. |
23 | 卢 阳, 李 薇, 崔久嵬, 等. 胡桃醌对人结肠癌HCT-8细胞黏附及基质金属蛋白酶活性的影响[J]. 吉林大学学报(医学版), 2012, 38(1): 89-92. |
24 | ZHANG S R, FU Z X, WEI J L, et al. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer[J]. Med Oncol, 2015, 32(1): 414. |
25 | 冯继红,张 红,李龙梅,等.基因沉默PRDX1表达对人结直肠癌SW480细胞侵袭迁移的影响[J].中国免疫学杂志,2017,33(7):1048-1052. |